Cargando…
Pediatric Intensive Care: Immunomodulation With Activated Protein C ex vivo
Objective: Sepsis is major cause of morbidity and mortality in the Pediatric Intensive Care Unit (PICU). PICU patients may develop transient immune deficiency during sepsis. Activated Protein C (APC) has significant anti-inflammatory and cytoprotective effects. Clinical trials of APC in adult sepsis...
Autores principales: | Eliwan, Hassan O., Watson, William R. G., Regan, Irene, Philbin, Brian, O'Hare, Fiona M., Strickland, Tammy, O'Neill, Amanda, O'Rourke, Michelle, Blanco, Alfonso, Healy, Martina, Nolan, Beatrice, Smith, Owen, Molloy, Eleanor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776988/ https://www.ncbi.nlm.nih.gov/pubmed/31612119 http://dx.doi.org/10.3389/fped.2019.00386 |
Ejemplares similares
-
Protein C Pathway in Paediatric and Neonatal Sepsis
por: Eliwan, Hassan, et al.
Publicado: (2022) -
Neonatal Encephalopathy Is Associated With Altered IL-8 and GM-CSF Which Correlates With Outcomes
por: Sweetman, Deirdre U., et al.
Publicado: (2021) -
Melatonin as an immunomodulator in children with Down syndrome
por: Huggard, Dean, et al.
Publicado: (2021) -
Neonatal Encephalopathy: Need for Recognition of Multiple Etiologies for Optimal Management
por: Aslam, Saima, et al.
Publicado: (2019) -
Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin
por: Tan, Bee K., et al.
Publicado: (2009)